Patient Financial Assistance Programs: A Path to Affordability or a Barrier to Accessible Cancer Care?
Publication
, Journal Article
Zafar, SY; Peppercorn, JM
Published in: J Clin Oncol
July 1, 2017
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Clin Oncol
DOI
EISSN
1527-7755
Publication Date
July 1, 2017
Volume
35
Issue
19
Start / End Page
2113 / 2116
Location
United States
Related Subject Headings
- Quality Indicators, Health Care
- Oncology & Carcinogenesis
- Neoplasms
- Medical Assistance
- Insurance, Health
- Humans
- Healthcare Disparities
- Health Services Accessibility
- Health Expenditures
- Drug Industry
Citation
APA
Chicago
ICMJE
MLA
NLM
Zafar, S. Y., & Peppercorn, J. M. (2017). Patient Financial Assistance Programs: A Path to Affordability or a Barrier to Accessible Cancer Care? J Clin Oncol, 35(19), 2113–2116. https://doi.org/10.1200/JCO.2016.71.7280
Zafar, S Yousuf, and Jeffrey M. Peppercorn. “Patient Financial Assistance Programs: A Path to Affordability or a Barrier to Accessible Cancer Care?” J Clin Oncol 35, no. 19 (July 1, 2017): 2113–16. https://doi.org/10.1200/JCO.2016.71.7280.
Zafar SY, Peppercorn JM. Patient Financial Assistance Programs: A Path to Affordability or a Barrier to Accessible Cancer Care? J Clin Oncol. 2017 Jul 1;35(19):2113–6.
Zafar, S. Yousuf, and Jeffrey M. Peppercorn. “Patient Financial Assistance Programs: A Path to Affordability or a Barrier to Accessible Cancer Care?” J Clin Oncol, vol. 35, no. 19, July 2017, pp. 2113–16. Pubmed, doi:10.1200/JCO.2016.71.7280.
Zafar SY, Peppercorn JM. Patient Financial Assistance Programs: A Path to Affordability or a Barrier to Accessible Cancer Care? J Clin Oncol. 2017 Jul 1;35(19):2113–2116.
Published In
J Clin Oncol
DOI
EISSN
1527-7755
Publication Date
July 1, 2017
Volume
35
Issue
19
Start / End Page
2113 / 2116
Location
United States
Related Subject Headings
- Quality Indicators, Health Care
- Oncology & Carcinogenesis
- Neoplasms
- Medical Assistance
- Insurance, Health
- Humans
- Healthcare Disparities
- Health Services Accessibility
- Health Expenditures
- Drug Industry